Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NHS Long Term Plan

- PMLiVE

NICE backs Astellas’ Xtandi in prostate cancer

But company criticises restrictions imposed by HTA body for England

- PMLiVE

NICE set to extend MabThera recommendation

Says Roche’s drug can be used on NHS to treat two serious forms of vasculitis

- PMLiVE

Raising awareness of community pharmacy

Many of the public remain unaware of the support on offer from community pharmacies

- PMLiVE

Skills in healthcare: pharmacy challenges in the UK

The challenges today’s pharmacists face

- PMLiVE

The future shape of pharmacy

Change is needed, particularly when it comes to commissioning, leadership and collaborative working

- PMLiVE

ABPI names NHS partnership manager

Raj Tugnet will lead work to strengthen pharma/NHS collaboration in UK

- PMLiVE

New medical director for Healthcare UK

Rory Shaw to lead team to spread NHS expertise worldwid

UK flag

NHS medicine spend to remain flat for two years

But UK drug pricing deal stops short of PPRS overhaul to value-based system

- PMLiVE

Innovative care partnerships

How forward-thinking service commissioners are tackling the need to provide a cost-efficient health service for an increasingly ageing and demanding population

- PMLiVE

To name and shame substandard healthcare?

Improving care by ‘naming and shaming’ hospitals or doctors remains a thorny issue

- PMLiVE

Driving good practice in homecare

The release of new professional standards looks to underpin the quality, and continued rise, of homecare services in the UK

- PMLiVE

Novartis’ Lucentis wins fourth NICE recommendation

But eye drug only recommended after a price-cutting patient access scheme offered

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links